Insider Trading March 6, 2026

Baldwin Insurance Insider Sale: 10% Owner Converts Class B and Sells $2.55M in Class A Shares

Elizabeth Krystyn disposes of 120,000 Class A shares amid recent stock weakness; mixed signals from earnings and analyst actions persist

By Leila Farooq BWIN
Baldwin Insurance Insider Sale: 10% Owner Converts Class B and Sells $2.55M in Class A Shares
BWIN

Elizabeth Krystyn, a member of Baldwin Insurance Group's 10% Owner Group, sold 120,000 Class A shares on March 6, 2026, for $2,549,723 at $21.25 per share. The transaction followed a conversion of 120,000 Class B shares into Class A shares at a conversion price of $0.0. Baldwin’s shares have suffered notable declines across multiple time horizons even as the company posted an earnings beat for the fourth quarter of 2025 and received an analyst upgrade from Raymond James.

Key Points

  • Elizabeth Krystyn, a 10% owner group member, sold 120,000 Class A shares on March 6, 2026, for $2,549,723 at $21.25 per share.
  • The sale followed the conversion of 120,000 Class B shares into Class A shares at a conversion price of $0.0; Baldwin’s stock has fallen 47% over the past year and 34% in six months.
  • Baldwin beat fourth-quarter 2025 adjusted EPS expectations ($0.31 reported vs $0.29 expected) but missed revenue forecasts slightly ($347.3M reported vs $351.93M expected); Raymond James upgraded the stock to Strong Buy and raised its price target to $30 from $20.

Summary - Elizabeth Krystyn, listed among Baldwin Insurance Group, Inc.'s (NASDAQ:BWIN) 10% Owner Group, effected a sale of 120,000 shares of Class A Common Stock on March 6, 2026, generating proceeds of $2,549,723. The shares were sold at $21.25 each, marginally above the then-current market price of $21.03.

The transaction was linked to a conversion event in which 120,000 shares of Class B Common Stock were converted into an equal number of Class A shares at a reported conversion price of $0.0. The sale occurred against a backdrop of sustained share-price erosion - the stock has fallen 47% over the trailing 12 months and 34% over the prior six months.

Market research referenced in connection with the filing indicates an InvestingPro view that Baldwin Insurance is trading below its Fair Value and appears on a Most Undervalued list. The same source notes that supplemental InvestingPro material, including six additional InvestingPro Tips and a Pro Research Report, is available for users seeking deeper analysis.


Recent financial results and analyst activity

Baldwin reported fourth-quarter 2025 adjusted earnings per share of $0.31, which exceeded analyst expectations of $0.29. Revenue for the quarter came in at $347.3 million, modestly below the forecasted $351.93 million. Market commentary following the report included an upward revision by Raymond James, which moved its rating on Baldwin Insurance to Strong Buy from Outperform and raised its price target to $30.00 from $20.00.

Despite the quarterly EPS beat and the analyst upgrade, the company's share price fell substantially over the past year and within 2025. The stock declined 36% in 2025 and is down 23% year-to-date. Observers point to several headwinds cited in market discussion: concerns related to AI, near-term pressure on organic revenue growth, investor views on the firm’s mergers and acquisitions approach, elevated debt leverage, and ongoing adjustments to reported income and cash flow.

Context and current posture

Taken together, the insider sale and the conversion of Class B to Class A shares are contemporaneous with mixed corporate signals - an earnings beat and an external upgrade on the one hand, and pronounced share-price declines and operational concerns on the other. Company disclosures and third-party research referenced in the filing indicate ongoing strategic initiatives aimed at positioning the business for future growth, though those initiatives are described in general terms in the materials cited.

Investors and market participants reviewing the filing should weigh the sale and conversion alongside the company’s recent financial performance, analyst reassessments, and the market’s recent pricing of Baldwin’s shares.

Risks

  • Shares have experienced significant declines (47% over 12 months, 34% over six months), reflecting market skepticism that could pressure equity valuations - relevant to equity markets and investor sentiment.
  • Near-term challenges cited include concerns about AI and pressures on organic revenue growth, which may affect the company’s top-line trajectory and investor expectations - relevant to technology adoption impacts and insurance sector revenue dynamics.
  • Investor worries tied to Baldwin’s mergers and acquisitions strategy, elevated debt leverage, and adjustments to income and cash flow could continue to influence the stock and the company’s financial flexibility - relevant to corporate finance and credit-sensitive markets.

More from Insider Trading

BofA Operations Chief Disposes $2.49M in Stock as Bank Advances Multiple Capital Plans Mar 7, 2026 Century Aluminum Executive Sells $563,300 in Stock Amid Strong Share Gains Mar 7, 2026 Perimeter Solutions Director Disposes $7.8M in PRM Shares Over Three Days Mar 7, 2026 TransMedics Director Disposes $178K of Stock as Company Posts Strong Q4 and Ups Guidance Mar 7, 2026 Krystal Biotech CEO Disposes $6.58M in Stock Under Prearranged Plan; Shares Trading Below Fair Value Estimate Mar 7, 2026